72 related articles for article (PubMed ID: 33888868)
1. Extramedullary infiltration in pediatric acute myeloid leukemia: Results from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative.
Li W; Shi M; Zhou P; Liu Y; Liu X; Xiao X; Zuo S; Bai Y; Sun K
Pediatr Blood Cancer; 2024 Jul; 71(7):e31014. PubMed ID: 38644612
[TBL] [Abstract][Full Text] [Related]
2. BATF promotes extramedullary infiltration through TGF-β1/Smad/MMPs axis in acute myeloid leukemia.
Zhang R; Miao J; Zhai M; Liu R; Li F; Xu X; Huang L; Wang T; Yang R; Yang R; Wang Y; He A; Wang J
Mol Carcinog; 2024 Jun; 63(6):1146-1159. PubMed ID: 38477642
[TBL] [Abstract][Full Text] [Related]
3. miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers.
Cheng YC; Fan Z; Liang C; Peng CJ; Li Y; Wang LN; Luo JS; Zhang XL; Liu Y; Zhang LD
Technol Cancer Res Treat; 2024; 23():15330338241248576. PubMed ID: 38693824
[No Abstract] [Full Text] [Related]
4. [Prognostic Value of
LE N; Yang JJ; Liu YC; Zhang XW; Wang H; Wen YN; Jiao YF; Wang LL; Dou LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):355-364. PubMed ID: 38660836
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of EZH2 in Acute Myeloid Leukemia.
Jiao W; Liu Y; Bao Y
Comput Intell Neurosci; 2022; 2022():8741989. PubMed ID: 36052036
[TBL] [Abstract][Full Text] [Related]
6. Aging-related genes related to the prognosis and the immune microenvironment of acute myeloid leukemia.
Gang D; Jiang Y; Wang X; Zhou J; Zhang X; He X; Dong R; Huang Z; Jiang S
Clin Transl Oncol; 2023 Oct; 25(10):2991-3005. PubMed ID: 37067728
[TBL] [Abstract][Full Text] [Related]
7. CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia.
Farge T; Nakhle J; Lagarde D; Cognet G; Polley N; Castellano R; Nicolau ML; Bosc C; Sabatier M; Sahal A; Saland E; Jeanson Y; Guiraud N; Boet E; Bergoglio C; Gotanègre M; Mouchel PL; Stuani L; Larrue C; Sallese M; De Mas V; Moro C; Dray C; Collette Y; Raymond-Letron I; Ader I; Récher C; Sarry JE; Cabon F; Vergez F; Carrière A
Cancer Res; 2023 Sep; 83(17):2824-2838. PubMed ID: 37327406
[TBL] [Abstract][Full Text] [Related]
8. Isolation of lymph shows dysregulation of STAT3 and CREB pathways in the spleen and liver during leukemia development in a rat model.
Steinskog ESS; Finne K; Enger M; Helgeland L; Iversen PO; McCormack E; Wiig H; Tenstad O
Microcirculation; 2023 Apr; 30(2-3):e12800. PubMed ID: 36702790
[TBL] [Abstract][Full Text] [Related]
9. Personalized therapy guided by single-cell transcriptomic analysis in relapsed and refractory KMT2A::MLLT10 AML with extensive extramedullary infiltration: A case report.
Wang R; Wu Y; Xue R; Shi T; Gu H; Yang Y; Wu W; Yang Y; Sun S; Zhu HH
Br J Haematol; 2024 May; ():. PubMed ID: 38740515
[No Abstract] [Full Text] [Related]
10. Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology.
Zorn KE; Cunningham AM; Meyer AE; Carlson KS; Rao S
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900239
[TBL] [Abstract][Full Text] [Related]
11. C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse.
Yang LX; Zhang CT; Yang MY; Zhang XH; Liu HC; Luo CH; Jiang Y; Wang ZM; Yang ZY; Shi ZP; Yang YC; Wei RQ; Zhou L; Mi J; Zhou AW; Yao ZR; Xia L; Yan JS; Lu Y
Blood; 2023 Feb; 141(7):766-786. PubMed ID: 36322939
[TBL] [Abstract][Full Text] [Related]
12. Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients.
Butrym A; Rybka J; Baczyńska D; Poręba R; Kuliczkowski K; Mazur G
Oncotarget; 2016 May; 7(21):30250-7. PubMed ID: 26862847
[TBL] [Abstract][Full Text] [Related]
13. HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma.
He S; Yang S; Niu M; Zhong Y; Dan Gao ; Zhang Y; Ma H; Xiong W; Zhou M; Zhou Y; Xiang B; Li G; Shuai C; Peng S
Cell Death Dis; 2018 Jan; 9(2):100. PubMed ID: 29367693
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting cyclin B2.
Li H; Tian X; Wang P; Huang M; Xu R; Nie T
Cell Mol Biol Lett; 2019; 24():66. PubMed ID: 31844417
[TBL] [Abstract][Full Text] [Related]
15. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
16. MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
Bao F; Zhang L; Pei X; Lian C; Liu Y; Tan H; Lei P
PLoS One; 2021; 16(9):e0256995. PubMed ID: 34587164
[TBL] [Abstract][Full Text] [Related]
17. miR-29c&b2 encourage extramedullary infiltration resulting in the poor prognosis of acute myeloid leukemia.
Wei Y; Lu W; Yu Y; Zhai Y; Guo H; Yang S; Zhao C; Zhang Y; Liu J; Liu Y; Fei J; Shi J
Oncogene; 2021 May; 40(19):3434-3448. PubMed ID: 33888868
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
